Optimizing Treatment in Patients with ROS1 Rearranged NSCLC cover art

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

By: Annenberg Center for Health Sciences
Listen for free

About this listen

 Greater understanding and implementation of molecular biomarkers in non-small cell lung cancer (NSCLC) have led to improved patient outcomes. However, optimizing therapeutic strategies for patients with a molecular alteration continues to be challenging for the multidisciplinary team. Among these alterations, ROS1 rearrangements are rare, but have important clinical implications.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
activate_mytile_page_redirect_t1
Episodes
  • Introduction and Key Takeaways

    Introduction and Key Takeaways
    Oct 7 2024

    This full educational program can be accessed at no cost here: https://annenberg.net/courses/landingPage.php?courseID=61030
    Show More Show Less
    15 mins

What listeners say about Optimizing Treatment in Patients with ROS1 Rearranged NSCLC

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.